Herpes simplex virus type 2 and cancer: a medical geography approach

Infect Genet Evol. 2011 Aug;11(6):1239-42. doi: 10.1016/j.meegid.2011.04.009. Epub 2011 Apr 15.

Abstract

Herpes simplex virus type-2 (HSV-2) has been identified as a possible aetiological agent of cancer in humans, especially prostate cancer, but results remain controversial. Here, we have addressed this question using a medical geography approach based on the national incidence of various cancers and seroprevalence of HSV-2 in 64 countries worldwide. We corrected reports of cancer incidence for national gross domestic product (GDP) because living in a wealthy nation likely increases the probability of having a cancer detected. Data were also corrected for latitude and diet. Our analysis not only confirms that prostate cancer and HSV-2 seroprevalence are positively associated, but it also reveals the existence of a positive relationship between HSV-2 and melanoma incidence in both men and women. These results, though correlational, suggest that HSV-2 should continue to be investigated as a possible oncogenic pathogen of humans.

MeSH terms

  • Adult
  • Female
  • Herpes Genitalis / complications
  • Herpes Genitalis / epidemiology*
  • Herpesvirus 2, Human*
  • Humans
  • Linear Models
  • Male
  • Melanoma / epidemiology*
  • Melanoma / virology
  • Prevalence
  • Prostatic Neoplasms / epidemiology*
  • Prostatic Neoplasms / virology
  • Young Adult